Suppr超能文献

非典型导管增生何时需要手术切除?

When Does Atypical Ductal Hyperplasia Require Surgical Excision?

作者信息

Racz Jennifer M, Degnim Amy C

机构信息

Department of Surgery, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA.

Department of Surgery, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA.

出版信息

Surg Oncol Clin N Am. 2018 Jan;27(1):23-32. doi: 10.1016/j.soc.2017.07.011.

Abstract

Atypical ductal hyperplasia (ADH) is a proliferative, nonobligate precursor breast lesion and a marker of increased risk for breast carcinoma. Surgical excision remains the standard recommendation following a core needle biopsy result consistent with ADH. Recent research suggests that women with no mass lesion or discordance, removal of greater than or equal to 90% of calcifications at the time of core needle biopsy, involvement of less than or equal to 2 terminal duct lobular units, and absence of cytologic atypia or necrosis are likely to have a less than 5% chance of a missed cancer.

摘要

非典型导管增生(ADH)是一种增殖性、非必然发展的乳腺前驱病变,也是乳腺癌风险增加的一个标志物。在粗针活检结果符合ADH后,手术切除仍是标准的推荐治疗方法。最近的研究表明,对于没有肿块病变或不一致情况、在粗针活检时钙化灶清除率大于或等于90%、累及的终末导管小叶单位小于或等于2个且不存在细胞学异型性或坏死的女性,漏诊癌症的可能性可能小于5%。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验